Upload
elvin-sparks
View
219
Download
2
Tags:
Embed Size (px)
Citation preview
Background information
• Antimicrobial peptides
• Intestinal epithelial cells regulate immune-cell function
• Virulence plasmid is essential forShigella pathogenesis
• Pathogenesis of Shigella
Antimicrobial peptides (AMPs)
• also called host defense peptides• small peptides with broad spectrum antimicrobial activity against bacteria, fungi, viruses• ubiquitously expressed by epithelial cells throughout the GI tract• usually positively charged (cationic peptides)• play an important role in controlling the resident and transient bacterial populations
E.g. of AMPsDefensinsCathelicidinHistatinsCathepsin GAzurocidinLatoferrin
Antimicrobial peptides (AMPs)
•
SP – Signal peptide
Human defensins α- defensins (neutrophil granules)β- defensins (HBD1, HBD2, HBD3, HBD4)
Intestinal epithelial cells regulate immune-cell function
• physical barrier• immune barrier
Glycocalyx - polysaccharides that projects from cell surfaceDefensin – a host defense peptide with antimicrobial activity
Virulence plasmid is essential forShigella pathogenesis
I have well equipped machinery
Shigella
TTSS
• Invasion plasmid antigens (Ipa )
• Membrane expression of Ipas (Mxi)
• Surface presentation of invasion plasmid antigens (Spa)
• Intracellular spread (IcsA or VirG)
• Type III Secretory System - TTSS (encoded by Mxi and Spa)
Pathogenesis of Shigella
Synopsis
In vitro studies – • Human intestinal cell lines were infected with Shigella flexneri• Observed suppression of transcription of genes mainly coding for antimicrobial peptides, like β-defensin (e.g., hBD-3), in these cell lines• MxiE (bacterial regulator) is responsible for such regulatory process
In vivo studies –• Human intestinal xenotransplants were used as model, infected with S.flexneri• Confirmed = MxiE dependent system that allows Shigella to suppress expression of antimicrobial peptides • This helps Shigella to progress deeper into intestinal crypts, thereby causing the disease• Down-regulation of additional innate immunity genes (e.g., CCL20) leading to compromised recruitment of DCs at infected area
Targeted survival strategy used by Shigella to survive in
the host by weakening the host immune system and thus
surviving in the intestine
Different strains of Shigella
• invasive wild-type strain M90T (virulent factors and TTSS system loaded)
• invasive mxiE mutant (impaired for the MxiE transcriptional activator regulating
expression of several virulence plasmid-encoded effectors, e.g., Osp and IpaH, but
TTSS functioning)
• non-invasive mxiD mutant (impaired for the MxiD protein, a component of the
TTSS
required for its functionality )
• non-invasive plasmid-cured BS176 strain
Antimicrobial factors gene expression
• ß defencins – HBD1, HBD2, HBD3
• cathelicidin – LL37
• CCL20 and its receptor CCR6
TC7 and HT29 colonic epithelial cell lines, Human intersinal xenografts in SCID
mice
Experimental Details
Results – Figure 1 (A and B)Virulent S. flexneri modulates expression of specific innate immune genes in vitro
M90TBS176mxiDmxiE
Results – Figure 1 (C and D)Virulent S. flexneri modulates expression of specific innate immune genes in vitro
S. flexneri is unable to significantly invade polarized and differentiated TC7and HT29 epithelial cells
MOI = multiplicity of infection (100)
TC7HT29
Gentamicin assay Lactate de-hydrogenase assay
Cellular viability is same M90T was unable to significantly invade cells
• wt S. flexneri impairs the expression of specific innate immunity genes by
injecting virulent factors into epithelial cells through its TTSS, thereby
affecting the host immune system
• MxiE dependent effectors are responsible for the observed manipulation
of
the host immune response through transcriptional damping
S. Flexneri >>>>> host innate immune parameter (e.g. defensins)
>>>>> role of bacteria’s MxiE and TTSS
Conclusion – Figure 1 (A to D)
TC7 cells stimulated by IL-1ß
UninfectedM90TBS176mxiDmxiE
Conclusion - S. flexneri manipulates the host innate immune response through injection of the Mxi-E dependent effectors even in the cells already expressing an inflammatory pattern
Results – Figure 2Virulent S. flexneri modulates expression of specific innate immune genes in vitro
Results – Figure 3 (A)Antimicrobial factors whose transcription is repressed by S. flexneri are those affecting the highest bactericidal activity against the pathogen
Experimental read out = DiBAC fluorescent molecule binds to depolarized membranes during bactericidal activity
M90TBS176mxiDmxiE
TC7
DiBAC = bis-(1,3-dibutylbarbituric acid)-tetramethylene oxonol fluorescent molecule
Results – Figure 3 (B)Antimicrobial factors whose transcription is repressed by S. flexneri are those affecting the highest bactericidal activity against the pathogen
Experimental read out = DiBAC fluorescent molecule binds to depolarized membranes during bactericidal activity
Listeria monocytogenes and L. innocua as control for experimental conditions
L. MonocytogenesesL. innocua
TC7
Conclusions – Figure 3 (A and B)
Among the antimicrobial molecules tested in vitro, hBD-3 is the most active antimicrobial factor for S. flexneri
From previous results - S. flexneri represses the transcription expression of HBD-3 gene
Results – Figure 4 (A)S. flexneri regulates expression of innate immunity genes in vivo
• Used human intestinal xenografts in SCID mice – chimerical structure, combining essentially human intestinal epithelium and mouse vascular and immune cells
• Essential tool for studying gene expression in human epithelial cells
• Focused on genes encoding chemokines, cytokines, and antimicrobial
peptides
Results – Figure 4 (A)
Total 46 genes whose expression was significantly modulated by S. flexneri
Of which 11 genes were less transcribed upon infection with M90T compared to mxiE or other strains
CCL3, CCL4, CCL20, CCL25, CCR12 – Mainly produced by EC, are involved in recruitment and activation of inflammatory and immune effector cells, like – monocytes, DCs, T cells
IL-7, IL-18, IL-13RA1, IL-20RA-Lymphocytes, IFN-γ
SOCS 3 (suppressor of cytokine signaling) – upregulated in M90T>>>>> involvement of Jak-Stat pathway in suppressing HBD1 and HBD3
Results – Figure 4 (B)S. flexneri regulates expression of innate immunity genes in vivo
M90TBS176mxiE
Xenografts
Conclusions – Figure 4 (A and B)
In vivo results show that S. flexneri is able to manipulate the host innate
response through MxiE-dependent effectors by up- or down-regulating
expression of crucial innate immunity genes
Results – Figure 5 (A-F)S. flexneri blocks antimicrobial factors expression in vivo
Immuno-histochemistry on infected human intestinal xenografts using antisera
to hBD1, hBD3, and CCL20 hBD1 hBD3 CCL20
M90T
mxiE
Weak labeling
Massive luminal release
Strong production
Weak production
Results – Figure S1 (A-F) – supplementary material S. flexneri blocks antimicrobial factors expression in vivo
hBD1 hBD3 CCL20
uninfected
mxiD
Massive luminal release Strong production
Conclusions – Figure 5 (A-F)
Mxi-E dependent S flexneri effectors affect the production of hBD-1, hBD-3
and CCL20 molecules exhibiting antimicrobial activities, thereby
weakening the
antimicrobial defense barrier at infected mucosal surfaces
hBD1 hBD3 CCL20
M90T
mxiE
uninfected
mxiD
hBD1 hBD3 CCL20
Results – Figure 6 (A-C)Blocking of antimicrobial factor expression correlates with deeper progression ofS. flexneri towards intestinal crypts
Bacterial counts in infected human intestinal xenografts using polyclonal antibody to S. flexneri 5a LPS - Qualitative analysis
M90T mxiE mxiD
Diffusely distributed in the mucus layer from the top of the villi to the crypts
Localized to the top of villi, trapped in luminal mucus
Results – Figure 6 (D)Blocking of antimicrobial factor expression correlates with deeper progression ofS. flexneri towards intestinal crypts
Bacterial counts in infected human intestinal xenografts using polyclonal antibody to S. flexneri 5a LPS - Quantitative analysis
M90TmxiEmxiD
Conclusions – Figure 6 (A-D)
Correlates the ability of S. flexneri to block antimicrobial factors
expression, and there capacity to progress deeply in intestinal crypts, at
the early time point of infection
Results – Figure 7 (A-D)S. flexneri compromises recruitment of DCs to the lamina propria of infected tissues
Immuno-histochemistry of infected intestinal xenografts by monoclonal
biotinylated antibody to mouse CD11c
M90T mxiE mxiD uninfected
Massive recruitment of DCs into the lamina propria and submucosal region
Restricted presence of DCs in submucosa And lamina propria
Conclusions – Figure 7 (A-D)
Existence of a dedicated MxiE-dependent system allowing S. flexneri to
suppress expression of immune effectors, leading to compromised
recruitment of DCs to lamina propria of infected tissues.
Synopsis
In vitro studies – • Human intestinal cell lines were infected with Shigella flexneri• Observed suppression of transcription of genes mainly coding for antimicrobial peptides, like β-defensin (e.g., hBD-3), in these cell lines• MxiE (bacterial regulator) is responsible for such regulatory process
In vivo studies –• Human intestinal xenotransplants were used as model, infected with S.flexneri• Confirmed = MxiE dependent system that allows Shigella to suppress expression of antimicrobial peptides • This helps Shigella to progress deeper into intestinal crypts, thereby causing the disease• Down-regulation of additional innate immunity genes (e.g., CCL20) leading to compromised recruitment of DCs at infected area
Thanks for your attention !!!
Infectious pathway for shigellosis
Shigella
• gram negative bacteria belongs to family Enterobacteriaceae• non-motile, rod shaped• causes disease called Shigellosis – bacillary dycentry (bloody diarrhea)• 4 species of Shigella – S. boydii, S. dycenteriae, S. flexneri, S. sonnei• can be treated by antibiotics• transmission via fecal-oral route • a very small inoculum (only 10-200 organisms) is sufficient to cause infection
Activities of Shigella type III secretion system (T3SS) effectors
Klotman et al. Nature Reviews Immunology 6, 447–456 (June 2006) | doi:10.1038/nri1860
Klotman et al. Nature Reviews Immunology 6, 447–456 (June 2006) | doi:10.1038/nri1860
Klotman et al. Nature Reviews Immunology 6, 447–456 (June 2006) | doi:10.1038/nri1860
A simplified model of membrane-ruffle production in response to the stimulation of host cellular signalling by Shigella effectors.
Shigella movement within the host-cell cytoplasm requires actin polymerization and microtubule degradation.
Shigella and the downregulation of the host inflammatory response.